StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Friday. The brokerage issued a sell rating on the stock.
Navidea Biopharmaceuticals Stock Performance
NYSE:NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.15. The firm has a 50-day moving average price of $0.02 and a two-hundred day moving average price of $0.04.
Navidea Biopharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Navidea Biopharmaceuticals
- Business Services Stocks Investing
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Call Options Volume for These 2 Stocks Spiked Together
- Roth IRA Calculator: Calculate Your Potential Returns
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.